Fighting variants of COVID-19

As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop and manufacture safe and effective vaccines. To date, two...
Read More
The latest: What they are saying: Intellectual property protections vital to COVID-19 research, development and manufacturing

Strong and reliable IP protections – including patents – have supported America’s robust innovation ecosystem by promoting discovery, development, affordability and access to new treatments and...
Read More
Lessons learned from COVID-19: The way we develop new medicines is changing

The COVID-19 pandemic has affected nearly every aspect of society, including the way scientists conduct the testing of medicines.
Read More
2020 FDA approvals show innovation despite COVID-19 pandemic challenges

A new report from the U.S. Food and Drug Administration (FDA) notes that the Center for Drug Evaluation and Research (CDER) approved 53 novel drugs last year. These figures are in addition to...
Read More
ICYMI: Cancer death rate continues decline due to advances in treatment

For the second year in a row, The American Cancer Society (ACS) reports a record single-year decline in cancer death rates in the United States. Each year, ACS estimates the number of new cancer...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
The latest: What they are saying: Intellectual property protections vital to incentivize ongoing COVID-19 research and development

America’s biopharmaceutical companies are committed to COVID-19 treatment and vaccine research and development (R&D). Reliable IP protections have helped drive innovation and enhance patient...
Read More
Guest Post: Bringing our best to the fight against COVID-19

Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...
Read More
Learning from history: How government price setting and other anti-innovation policies negatively impact biopharmaceutical R&D

Today, America leads the world in medical innovation because of our unique research ecosystem, but that wasn’t always the case. A new paper from NDP Analytics, “Will US Leadership in...
Read More
Understanding the emergency use authorization process for COVID-19 vaccines

As the world continues to feel the impact of the COVID-19 pandemic, the biopharmaceutical industry is working around the clock to develop safe and effective vaccines to prevent infection, as well...
Read More